February 23, 2023 Westat has a long history of working with Medidata Solutions and is proud to celebrate an official 5 years of partnership. Ravi Rajaram, Westat’s Vice President and Associate Director for Clinical Research, notes, “As a Medidata partner, we use Rave solutions on a unified study platform, giving clients the confidence that our … Read more
February, 9, 2023 Jennifer Fulton, Senior Biostatistician and Stephen Black, Manager of Statistics February 2023 Implementing the Clinical Data Interchange Standards Consortium (CDISC) standards required for data management, programming, documentation, and eCTD data submission can be challenging for many reasons but is essential for increased quality and efficiency, leading to clinical research breakthroughs. If you … Read more
Jan 25, 2021 Deepak Khatry, Ph.D., a Westat Associate Director and a clinical trials biostatistician, has written Evidence Derived from Real-World Data (RWD): Utility, Constraints, and Cautions, the second chapter in a new book: Real-World Evidence in Drug Development and Evaluation, published in 2021 under the Biostatistics Series of Chapman & Hall/CRC Press. Dr. Khatry addresses He … Read more
November 29, 2022 Westat staff are providing research findings to the 22nd International Congress on Nutrition, to be held in Tokyo, Japan, December 6-11, 2022. The theme is The Power of Nutrition: For the Smiles of 10 Billion People. This important conference, which is held every 4 years, takes place considering the number of nutrition issues … Read more
September 12, 2022 Westat expertise in is on hand at the 24th SCDM Annual Conference, held September 11-14, 2022, in San Antonio, Texas. The conference is considered the world’s leading clinical data management (CDM) conference, providing the opportunity for CDM knowledge sharing and education. Westat’s Ginger Riley and coauthor Neesha Desai will present : Adoption … Read more
September 12, 2022 Westat site monitoring expertise will be spotlighted in 2 posters at the 31st Annual SOCRA Conference, which will be held virtually September 14-17, 2022. The conference enables the global clinical research community to come together and work toward safe, efficient, and quality clinical research. Isabel Trejos and Silvia Jimenez are presenting a poster about … Read more
July 28, 2022 Lauren Laimon, M.S., a Westat Senior Study Director for Clinical Trials, has been selected as one of the 2022 Top 50 Women Leaders of Maryland by Women We Admire. The organization provides news and information on today’s women leaders in the state, recognizing the achievements of exceptional women and their dedication to … Read more
July 29, 2022 Built on a long-standing partnership with TaiMed Biologics, Inc., (TaiMed), Westat and TaiMed have announced the first patient has been enrolled in the new TMB-a21 study. TMB-a21 is a Phase 1b/2a study involving HIV-1 infected patients who are virally suppressed. The investigational products, TMB-365 and TMB-380, are monoclonal antibodies administered together via … Read more
March 2, 2021 Increasing patient enrollment to clinical trials continues to be challenging despite efforts to identify multiple physician, patient, and system barriers. One way to alleviate this problem is to expand demographic and comorbidity data collection. This additional information can then enhance our understanding of the barriers, develop interventions to overcome them, and recognize … Read more
April 29, 2021 Pneumococcus is a significant danger to pregnant women with HIV and their infants. PCV-10 and PPV-23 are 2 vaccines that help protect against invasive disease like pneumococcus. New research has compared the safety and immunogenicity of PCV-10 and PPV-23 administered in pregnancy. In a new article published in the Lancet, Westat’s Lauren Laimon, M.S., … Read more